Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Jomaa Pharma GmbH
Country
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria
Phase 2
Conditions
Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Interventions
Drug: Fosmidomycin-Piperaquine
Subscribe
First Posted Date
2014-07-24
Last Posted Date
2015-06-15
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
100
Registration Number
NCT02198807
Subscribe
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children
Phase 2
Completed
Conditions
Malaria
Interventions
Drug: Fosmidomycin and Clindamycin co-administration
Subscribe
First Posted Date
2011-11-03
Last Posted Date
2011-11-03
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
52
Registration Number
NCT01464138
Locations
🇲🇿
Centro de Investigacao em Saude da Manhica, Maputo, Mozambique
Subscribe
Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
Phase 2
Conditions
Malaria
Interventions
Drug: Fosmidomycin
Drug: Azithromycin
Subscribe
First Posted Date
2011-11-03
Last Posted Date
2011-11-03
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
43
Registration Number
NCT01464125
Locations
🇹ðŸ‡
Mahidol University, Bangkok, Thailand
Subscribe
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate
Phase 2
Withdrawn
Conditions
Malaria
Interventions
Drug: Fosmidomycin
Subscribe
First Posted Date
2009-10-27
Last Posted Date
2011-09-27
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
40
Registration Number
NCT01002183
Locations
🇹ðŸ‡
Mahidol University, Bangkok, Thailand
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy